Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / Common Stock
Shares outstanding
263,222,327
Total 13F shares
15,836,572
Share change
+1,028,933
Total reported value
$204,569,610
Put/Call ratio
21%
Price per share
$12.92
Number of holders
88
Value change
+$19,766,036
Number of buys
52
Number of sells
31

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EAGLE ASSET MANAGEMENT INC
13F
Company
1.2%
3,268,077
$31,569,000 30 Sep 2015
13F
FMR LLC
13F
Company
0.75%
1,965,600
$18,988,000 30 Sep 2015
13F
Novo Holdings A/S
13F
Company
0.58%
1,516,387
$14,648,000 30 Sep 2015
13F
BlackRock Fund Advisors
13F
Company
0.39%
1,021,144
$9,864,000 30 Sep 2015
13F
VANGUARD GROUP INC
13F
Company
0.23%
613,837
$5,930,000 30 Sep 2015
13F
Visium Asset Management, LP
13F
Company
0.21%
556,000
$5,371,000 30 Sep 2015
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.21%
546,316
$5,277,000 30 Sep 2015
13F
ALPS ADVISORS INC
13F
Company
0.02%
45,137
$4,360,000 30 Sep 2015
13F
STIFEL FINANCIAL CORP
13F
Company
0.17%
445,100
$4,297,000 30 Sep 2015
13F
MARSHALL WACE, LLP
13F
Company
0.16%
428,032
$4,135,000 30 Sep 2015
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.12%
328,671
$3,175,000 30 Sep 2015
13F
STATE STREET CORP
13F
Company
0.11%
277,138
$2,679,000 30 Sep 2015
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.1%
260,000
$2,512,000 30 Sep 2015
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
0.1%
256,450
$2,477,000 30 Sep 2015
13F
Informed Momentum Co LLC
13F
Company
0.09%
241,440
$2,332,000 30 Sep 2015
13F
NORTHERN TRUST CORP
13F
Company
0.09%
233,242
$2,253,000 30 Sep 2015
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
212,086
$2,049,000 30 Sep 2015
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.07%
173,334
$1,674,000 30 Sep 2015
13F
Bank of New York Mellon Corp
13F
Company
0.06%
146,150
$1,412,000 30 Sep 2015
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.05%
131,304
$1,268,000 30 Sep 2015
13F
P.A.W. CAPITAL CORP
13F
Company
0.05%
130,000
$1,256,000 30 Sep 2015
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.05%
129,144
$1,248,000 30 Sep 2015
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
127,691
$1,233,000 30 Sep 2015
13F
MORGAN STANLEY
13F
Company
0.04%
112,909
$1,091,000 30 Sep 2015
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
110,700
$1,069,000 30 Sep 2015
13F
Cormorant Asset Management, LP
13F
Company
0.04%
100,300
$969,000 30 Sep 2015
13F
JOHNSON INVESTMENT COUNSEL INC
13F
Company
0.04%
98,001
$946,000 30 Sep 2015
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
96,650
$934,000 30 Sep 2015
13F
BlackRock Investment Management, LLC
13F
Company
0.04%
94,604
$914,000 30 Sep 2015
13F
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
13F
Company
0.04%
94,000
$908,000 30 Sep 2015
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.03%
89,425
$864,000 30 Sep 2015
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
84,138
$813,000 30 Sep 2015
13F
Trexquant Investment LP
13F
Company
0.03%
72,500
$700,000 30 Sep 2015
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.02%
64,953
$627,000 30 Sep 2015
13F
CITADEL ADVISORS LLC
13F
Company
0.02%
63,802
$616,000 30 Sep 2015
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13F
Company
0.02%
63,016
$609,000 30 Sep 2015
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
62,187
$601,000 30 Sep 2015
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.02%
60,000
$580,000 30 Sep 2015
13F
RUSSELL FRANK CO/
13F
Company
0.02%
54,918
$531,000 30 Sep 2015
13F
Nine Chapters Capital Management LLC
13F
Company
0.02%
50,900
$492,000 30 Sep 2015
13F
Employees Retirement System of Texas
13F
Company
0.02%
50,000
$483,000 30 Sep 2015
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
44,327
$428,000 30 Sep 2015
13F
EMERALD ADVISERS, LLC
13F
Company
0.02%
42,910
$415,000 30 Sep 2015
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.02%
42,700
$412,000 30 Sep 2015
13F
TEACHERS ADVISORS, LLC
13F
Company
0.01%
35,254
$341,000 30 Sep 2015
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.01%
33,733
$326,000 30 Sep 2015
13F
STONERIDGE INVESTMENT PARTNERS LLC
13F
Company
0.01%
33,406
$323,000 30 Sep 2015
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
33,148
$320,000 30 Sep 2015
13F
UBS Group AG
13F
Company
0.01%
33,049
$319,000 30 Sep 2015
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
31,788
$307,000 30 Sep 2015
13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2015

As of 31 Dec 2015, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,836,572 shares. The largest 10 holders included EAGLE ASSET MANAGEMENT INC, FMR LLC, BlackRock Fund Advisors, Visium Asset Management, LP, FIRST MANHATTAN CO, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, BlackRock Institutional Trust Company, N.A., EAM Investors, LLC, and Marshall Wace LLP. This page lists 88 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2015 vs Q3 2015 Across Filers

Q3 2015 holders
80
Q4 2015 holders
88
Holder diff
8
Investor Q3 2015 Shares Q4 2015 Shares Share Diff Share Chg % Q3 2015 Value $ Q4 2015 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.